Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3402)
uniQure N.V. (QURE)
KLEMT CHRISTIAN — Chief Financial Officer
Shares
12,000
Price
$9.06
Total Value
$108.72K
Shares Held After
226,581
% of Holdings
5.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
German Christopher Paul — Corporate Controller & CAO
Shares
5,614
Price
$89.56
Total Value
$502.79K
Shares Held After
160
% of Holdings
97.2%
PepGen Inc. (PEPG)
McArthur James G — Director
Shares
131
Price
$6.33
Total Value
$828.58
Shares Held After
296,326
% of Holdings
0.0%
PepGen Inc. (PEPG)
McArthur James G — Director
Shares
5,144
Price
$6.23
Total Value
$32.05K
Shares Held After
296,457
% of Holdings
1.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
2,437
Price
$475.30
Total Value
$1.16M
Shares Held After
15,122
% of Holdings
13.9%
PepGen Inc. (PEPG)
Donnelly Noel — Chief Financial Officer
Shares
52
Price
$6.33
Total Value
$328.90
Shares Held After
111,603
% of Holdings
0.0%
PepGen Inc. (PEPG)
Donnelly Noel — Chief Financial Officer
Shares
2,032
Price
$6.23
Total Value
$12.66K
Shares Held After
111,655
% of Holdings
1.8%
VERACYTE, INC. (VCYT)
Stapley Marc — Director
Shares
26,279
Price
$36.28
Total Value
$953.37K
Shares Held After
357,554
% of Holdings
6.8%
VERACYTE, INC. (VCYT)
Stapley Marc — Director
Shares
19,244
Price
$35.56
Total Value
$684.23K
Shares Held After
383,833
% of Holdings
4.8%
VERACYTE, INC. (VCYT)
Leite John — Chief Commercial Officer-CLIA
Shares
5,260
Price
$35.19
Total Value
$185.08K
Shares Held After
107,580
% of Holdings
4.7%
VERACYTE, INC. (VCYT)
McGuire Annie — SVP, General Counsel
Shares
1,664
Price
$36.34
Total Value
$60.47K
Shares Held After
94,706
% of Holdings
1.7%
VERACYTE, INC. (VCYT)
McGuire Annie — SVP, General Counsel
Shares
4,994
Price
$35.29
Total Value
$176.26K
Shares Held After
96,370
% of Holdings
4.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
223
Price
$325.67
Total Value
$72.62K
Shares Held After
61,805
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
291
Price
$324.88
Total Value
$94.54K
Shares Held After
62,028
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
818
Price
$323.84
Total Value
$264.90K
Shares Held After
62,319
% of Holdings
1.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
374
Price
$323.01
Total Value
$120.81K
Shares Held After
63,137
% of Holdings
0.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
309
Price
$321.82
Total Value
$99.44K
Shares Held After
63,511
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
230
Price
$320.81
Total Value
$73.79K
Shares Held After
63,820
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
109
Price
$320.01
Total Value
$34.88K
Shares Held After
64,050
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
114
Price
$319.03
Total Value
$36.37K
Shares Held After
64,159
% of Holdings
0.2%
PepGen Inc. (PEPG)
STRECK PAUL — EVP, Head of R&D
Shares
47
Price
$6.29
Total Value
$295.54
Shares Held After
76,226
% of Holdings
0.1%
PepGen Inc. (PEPG)
STRECK PAUL — EVP, Head of R&D
Shares
1,832
Price
$6.23
Total Value
$11.41K
Shares Held After
76,273
% of Holdings
2.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
208
Price
$325.67
Total Value
$67.74K
Shares Held After
21,097
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
272
Price
$324.88
Total Value
$88.37K
Shares Held After
21,305
% of Holdings
1.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
767
Price
$323.84
Total Value
$248.39K
Shares Held After
21,577
% of Holdings
3.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
350
Price
$323.01
Total Value
$113.05K
Shares Held After
22,344
% of Holdings
1.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
289
Price
$321.82
Total Value
$93.01K
Shares Held After
22,694
% of Holdings
1.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
215
Price
$320.81
Total Value
$68.97K
Shares Held After
22,983
% of Holdings
0.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
102
Price
$320.01
Total Value
$32.64K
Shares Held After
23,198
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
106
Price
$319.03
Total Value
$33.82K
Shares Held After
23,300
% of Holdings
0.5%
BridgeBio Pharma, Inc. (BBIO)
Ellis Andrea — Director
Shares
64,921
Price
$64.87
Total Value
$4.21M
Shares Held After
18,589
% of Holdings
77.7%
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
13,941
Price
$36.33
Total Value
$506.46K
Shares Held After
131,196
% of Holdings
9.6%
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
4,400
Price
$35.55
Total Value
$156.41K
Shares Held After
145,137
% of Holdings
2.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
265
Price
$325.67
Total Value
$86.30K
Shares Held After
95,695
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
345
Price
$324.88
Total Value
$112.08K
Shares Held After
95,960
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
973
Price
$323.84
Total Value
$315.10K
Shares Held After
96,305
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
444
Price
$323.01
Total Value
$143.42K
Shares Held After
97,278
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
368
Price
$321.82
Total Value
$118.43K
Shares Held After
97,722
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
274
Price
$320.81
Total Value
$87.90K
Shares Held After
98,090
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
129
Price
$320.01
Total Value
$41.28K
Shares Held After
98,364
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
135
Price
$319.03
Total Value
$43.07K
Shares Held After
98,493
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
208
Price
$325.67
Total Value
$67.74K
Shares Held After
34,297
% of Holdings
0.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
272
Price
$324.88
Total Value
$88.37K
Shares Held After
34,505
% of Holdings
0.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
767
Price
$323.84
Total Value
$248.39K
Shares Held After
34,777
% of Holdings
2.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
350
Price
$323.01
Total Value
$113.05K
Shares Held After
35,544
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
289
Price
$321.82
Total Value
$93.01K
Shares Held After
35,894
% of Holdings
0.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
215
Price
$320.81
Total Value
$68.97K
Shares Held After
36,183
% of Holdings
0.6%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
808
Price
$9.06
Total Value
$7.32K
Shares Held After
189,669
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
102
Price
$320.01
Total Value
$32.64K
Shares Held After
36,398
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
106
Price
$319.03
Total Value
$33.82K
Shares Held After
36,500
% of Holdings
0.3%
Showing 701–750 of 3402 transactions (page 15 of 69)